Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Hualu-Hengsheng Chemical Co., Ltd. is a leading Chinese multi-product chemical company specializing in coal-based chemicals and fertilizers. While primarily an industrial chemical producer, the company is a critical supplier to the life sciences industry as one of the world's largest manufacturers of organic amines, including dimethylformamide (DMF) and methylamines. These chemicals serve as essential solvents and intermediates in the synthesis of various active pharmaceutical ingredients (APIs) and other healthcare products. Headquartered in Dezhou, Shandong, the company operates highly integrated manufacturing platforms that leverage advanced coal gasification and carbonyl synthesis technologies. Hualu Hengsheng is listed on the Shanghai Stock Exchange and is recognized for its significant market share and cost-efficiency in the global chemical supply chain. The company does not maintain its own clinical drug pipeline, focusing instead on the upstream production of chemical building blocks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hualu Hengsheng.